Huberman: AI labs will become biotech to read your brain

Andrew Huberman, the Stanford neuroscientist, told the Invest Like The Best podcast that Meta, OpenAI, and Anthropic "will all become biotech companies," because they are "all interested in the brain." Business Insider reported the remarks this week.

The shared goal, he said, is to "read and write from your brain non-invasively." Huberman called that "the real arms race of AI."

The engineering problem he points at is unflashy: find a way, "most likely ultrasound, to stimulate or quiet specific brain areas" with spatial and temporal precision. The uses he lists are the familiar wellness ones (sleep, focus, stress), plus a wearable that could dial up motivation while someone tackles hard work and then switch that state off so the user can recover.

Huberman pulled Elon Musk's Neuralink into the same frame even though its current product is invasive, arguing the field will race toward doing the same thing without surgery. He went further, floating gene therapy that would modify neurons so a later wearable could activate them with light or ultrasound. "Sounds kind of science fiction," he conceded.